LANIA, Andrea Gerardo Antonio
 Distribuzione geografica
Continente #
NA - Nord America 7.684
AS - Asia 3.400
EU - Europa 1.561
SA - Sud America 1.116
AF - Africa 242
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.020
Nazione #
US - Stati Uniti d'America 7.600
SG - Singapore 2.178
BR - Brasile 951
CN - Cina 632
FI - Finlandia 342
IE - Irlanda 238
NG - Nigeria 191
IT - Italia 187
VN - Vietnam 183
DE - Germania 172
FR - Francia 139
GB - Regno Unito 107
NL - Olanda 102
HK - Hong Kong 94
AR - Argentina 76
IN - India 66
BD - Bangladesh 51
SE - Svezia 50
CA - Canada 48
RU - Federazione Russa 48
UA - Ucraina 26
EC - Ecuador 25
PK - Pakistan 24
MX - Messico 23
TR - Turchia 23
ID - Indonesia 22
ZA - Sudafrica 22
MK - Macedonia 21
PL - Polonia 20
AT - Austria 18
ES - Italia 18
IQ - Iraq 18
JP - Giappone 18
CO - Colombia 17
CL - Cile 16
BE - Belgio 15
IL - Israele 13
PY - Paraguay 11
UZ - Uzbekistan 11
AU - Australia 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
KE - Kenya 8
RO - Romania 8
VE - Venezuela 8
CH - Svizzera 7
LT - Lituania 7
PH - Filippine 7
HU - Ungheria 6
IR - Iran 6
MA - Marocco 6
UY - Uruguay 6
GR - Grecia 5
KR - Corea 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
EG - Egitto 4
GE - Georgia 4
LV - Lettonia 4
NP - Nepal 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EE - Estonia 3
GT - Guatemala 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
AZ - Azerbaigian 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
EU - Europa 2
HN - Honduras 2
MD - Moldavia 2
RS - Serbia 2
SN - Senegal 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
TG - Togo 1
TJ - Tagikistan 1
Totale 14.018
Città #
Chandler 1.207
Wilmington 1.051
Dallas 761
Singapore 637
The Dalles 494
San Mateo 402
Shanghai 387
Helsinki 342
Ann Arbor 337
New York 263
Ashburn 261
Dublin 237
Boardman 208
Lawrence 204
Princeton 204
Benin City 191
Leawood 179
Paris 125
Beijing 121
Hong Kong 92
Fairfield 87
Woodbridge 82
São Paulo 76
Ho Chi Minh City 74
Milan 73
Amsterdam 68
London 53
Los Angeles 48
Hanoi 42
Pune 34
Santa Clara 34
Seattle 33
Rio de Janeiro 31
Brooklyn 25
Norwalk 22
Belo Horizonte 20
Munich 20
Phoenix 20
Council Bluffs 19
Lahore 19
Naples 19
Buenos Aires 18
San Diego 18
Curitiba 17
Tokyo 17
Campinas 16
Porto Alegre 16
Brussels 15
Columbus 15
Montreal 14
Toronto 14
Warsaw 14
Dhaka 13
Atlanta 12
Johannesburg 12
Rome 12
San Francisco 12
Falkenstein 11
Goiânia 11
Recife 11
Assago 10
Boston 10
Manchester 10
Mumbai 10
Abbiategrasso 9
Chicago 9
Fortaleza 9
Frankfurt am Main 9
Kocaeli 9
Poplar 9
Salvador 9
Skopje 9
Tashkent 9
Uberlândia 9
Campo Grande 8
Guarulhos 8
Guayaquil 8
Haiphong 8
Natal 8
Quito 8
Ribeirão Preto 8
Stockholm 8
Brasília 7
Chennai 7
Da Nang 7
Moscow 7
Osasco 7
San Jose 7
Contagem 6
Hanover 6
Houston 6
Ipatinga 6
Manaus 6
Monmouth Junction 6
Nairobi 6
Orem 6
Redmond 6
Reston 6
Santo André 6
Secaucus 6
Totale 9.178
Nome #
CLINICAL PRESENTATION OF BONE METASTASES IN NEUROENDOCRINE TUMORS: A RETROSPECTIVE COHORT STUDY 358
Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry 187
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 182
Safety of Romosozumab in women with cancer and osteoporosis at high risk of fractures 163
A 2019 update on TSH-secreting pituitary adenomas 108
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 106
Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fractures 97
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 96
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 92
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal 88
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 87
G protein mutations in endocrine diseases 86
An Unusual Case of Recurrent Autoimmune Hypophysitis 86
Adequacy of current postglucose GH nadir limit (< 1 mu g/1) to define long-lasting remission of acromegalic disease 84
Activating mutations of the G(s)alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors 82
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients 81
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 81
Parental origin of G(s)alpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors 81
Central hypothyroidism and growth hormone treatment : clinical care 81
G-Protein and Signalling in Pituitary Tumours 80
A potential catastrophic trap: an unusually presenting sellar lesion 80
Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation 80
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 78
G protein abnormalities in pituitary adenomas 77
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype 75
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors 75
Growth factors and human pituitary adenomas 74
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 73
[18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results 73
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 72
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 71
Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation 71
Hormonal signaling and pituitary adenomas 70
A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells 70
Functional hypothalamic and drug-induced amenorrhea: an overview 69
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 68
The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk 68
Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior 68
Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms 67
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 67
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 67
Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome 67
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 67
A Multicenter Cohort Study in Patients With Primary Empty Sella: Hormonal and Neuroradiological Features Over a Long Follow-Up 66
Bone disorders associated with acromegaly: mechanisms and treatment 66
Complete Remission of Hepatic Metastasis after Total Gastrectomy for a Gastric Carcinoid Tumor Type 1: A Case Report 65
Filamin-A Is Essential for Dopamine D2 Receptor Expression and Signaling in Tumorous Lactotrophs 65
Thyrotoxicosis in patients with COVID-19: the THYRCOV study 65
Genetics of pituitary tumors: Focus on G-protein mutations 64
Central hypothyroidism - a neglected thyroid disorder 64
Pancreatic Neuroendocrine Tumours: The Role of Endoscopic Ultrasound Biopsy in Diagnosis and Grading Based on the WHO 2017 Classification 64
GNAS imprinting and pituitary tumors 63
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident 63
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 63
Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients 63
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 63
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 63
Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas 62
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 62
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 62
Inactivating and activating mutations of the Gs alpha gene 62
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 62
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 62
Biallelic expression of the Gs alpha gene in human bone and adipose tissue 61
cAMP in the pituitary: An old messenger for multiple signals 61
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 61
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues 61
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures. 61
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 61
Effect of cyclic adenosine 3 ',5 '-monophosphate/protein kinase A pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 61
Is the 250 mu g ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? 61
GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency 61
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma 60
Expression of the anti-apoptotic factor seladin-1 and induction of apoptosis in GH secreting adenomas and in non-functioning pituitary adenomas 60
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment 60
Levothyroxine supplementation on assisted reproduction technology (ART) outcomes in women with subtle hypothyroidism: a retrospective study 60
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management 60
Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas 59
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours 59
Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression 59
Dopamine D-2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas 59
Pituitary incidentalomas 58
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly 58
Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study 58
Endoscopic expanded endonasal approach: preliminary experience with the new 3D endoscope 58
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 58
Central hypothyroidism 58
Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation 58
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 58
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia 57
Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases 57
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function 57
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 57
Bilateral testicular masses and adrenal insufficiency: is congenital adrenal hyperplasia the only possible diagnosis? First two cases of TARTS described in Addison-only X-linked adrenoleukodystrophy and a brief review of literature 57
[Genetic changes in human pituitary adenomas] 57
A practical use of bone turnover markers in management of patients with skeletal fragility 56
Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells 56
Double Pituitary and Conserved Function in an Adult Patient with Neurofibromatosis Type 1 56
Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas 56
Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks 56
Totale 7.393
Categoria #
all - tutte 109.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.762 0 0 0 0 0 624 252 154 352 173 10 197
2021/20221.008 31 5 7 226 7 8 32 132 143 115 237 65
2022/20233.127 448 141 308 348 287 268 25 253 536 291 178 44
2023/20241.821 122 203 333 112 44 269 103 105 48 28 185 269
2024/20253.066 66 37 64 64 53 296 236 327 427 673 421 402
2025/20263.401 997 409 868 831 239 57 0 0 0 0 0 0
Totale 14.255